Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1205
Embargo will expire:
27-Jun-2018 1:00 PM EDT
Released to reporters:
22-Jun-2018 12:00 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 27-Jun-2018 1:00 PM EDT

Article ID: 696440

The Immune System: Cracking Open the Black Box

American Technion Society

A technology developed at Israel's Technion will provide the scientific community with novel tools to gain a comprehensive understanding of immune system activity. Based on millions of scientific publications, the technology uses artificial intelligence to map disease immune profiles. These maps, which have already identified previously unknown biological interactions, will enable development of personalized, immuno-centric therapies

Released:
21-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Emergency-large.jpg
  • Embargo expired:
    21-Jun-2018 7:00 AM EDT

Article ID: 696259

Majority of U.S. Adults Prescribed Epinephrine Report Not Using It in an Emergency

American College of Allergy, Asthma and Immunology (ACAAI)

A new study shows in an emergency, 52 percent of adults with potentially life-threatening allergies didn’t use the epinephrine auto-injectors (EAI) they were prescribed.

Released:
18-Jun-2018 1:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696368

Scientists Unravel DNA Code Behind Rare Neurologic Disease

UT Southwestern Medical Center

Scientists conducting one of the largest full DNA analyses of a rare disease have identified a gene mutation associated with a perplexing brain condition that blinds and paralyzes patients.

Released:
20-Jun-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696364

Fetal T cells are first responders to infection in adults

Cornell University

Cornell University researchers have discovered there is a division of labor among immune cells that fight invading pathogens in the body.

Released:
20-Jun-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites

Article ID: 696249

Seattle Children's Opens Immunotherapy Trial For Children With Relapsed Central Nervous System Tumors That Delivers CAR T Cells Directly Into the Brain

Seattle Children's Hospital

Seattle Children’s has opened a pioneering chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory HER2-positive central nervous system (CNS) tumors where CAR T cells will be delivered directly into the brain. In the phase I trial, BrainChild-01, cancer-fighting CAR T cells will be infused through a catheter, either into the cavity where the tumor has been removed or the CNS ventricular system, depending on the location of the tumor.

Released:
19-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Embargo will expire:
25-Jun-2018 9:00 AM EDT
Released to reporters:
19-Jun-2018 9:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Jun-2018 9:00 AM EDT

shutterstock_932892vaccinebullseye.jpg

Article ID: 696263

Exploring a New Treatment for Metastatic Colorectal Cancer

Rutgers Cancer Institute of New Jersey

Researchers at Rutgers Cancer Institute are exploring the combination of a new anti-cancer vaccine with an immunotherapy drug approved for use in other forms of cancer to determine if the combined treatment can prompt a patient’s natural defenses (the immune system) to attack their cancer and improve their survival.

Released:
19-Jun-2018 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Microgliaintheretina.jpg
  • Embargo expired:
    18-Jun-2018 3:00 PM EDT

Article ID: 696086

Microglia Protect Sensory Cells Needed for Vision After Retinal Detachment

Massachusetts Eye and Ear

A research team at Massachusetts Eye and Ear has shown that microglia, the primary immune cells of the brain and retina, play a protective role in response to retinal detachment.

Released:
13-Jun-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Pertussis.research.feature.jpg

Article ID: 696222

Researcher Pursues Updated Vaccine Against Whooping Cough

West Virginia University

To remain effective, the pertussis vaccine must be modified to keep pace with evolving bacteria. As the vaccines' efficacy is declining, Heath Damron, an assistant professor in the WVU School of Medicine, is pursuing innovations to strengthen the vaccine and still keep it safe.

Released:
18-Jun-2018 1:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 1205





Chat now!